Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of B1 and marginal zone B cells during ovarian cancer

Cellular Immunology(2023)10.1016/j.cellimm.2023.104788Source: DataRank Database

Loss of B1 and marginal zone B cells during ovarian cancer is a research paper published in Cellular Immunology (2023). On theSindex it has a DataRank of 0.114. It has been cited 1 time, with 1 citing works in its 1-hop citation network.

N/A

0.114DataRank · unranked

Scored on demand from live citation data

Open Access1 citations · 1 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.09)OA: greenTopics (37)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 91%Citation Network 9%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

0.0100

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 1 citer driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 1 citer.

Research progress on the cross-regulation between ferroptosis and immunogenic cell death in tumor micro-environment
Frontiers in Oncology202516 citations240 referencesContributes 0.012

Authors (7)

Gretel M. Torres ORCID,Jennifer Londregan ORCID,Naomi Goldman ORCID,Daniel Silberman,John E. Somerville

Live enrichment

PubMed:38000306 OpenAlex:https://openalex.org/W4388907711

National Institutes of Health

Grant: R15 AI 060356-01

National Institutes of Health

Grant: R15 CA 136901

NIAID NIH HHS

Grant: R15 AI060356

FWCI

0.09

Citation Percentile

0.4%

Citation Trend

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10842900/pdf/nihms-1947418.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0008874923001272?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0008874923001272?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10842900

Fields of Study

Immune Cell Function and InteractionT-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersHumansFemaleAnimalsMiceB-LymphocytesPeritoneumPeritoneal CavityB-Lymphocyte SubsetsOvarian NeoplasmsMice, Inbred C57BL

MeSH Terms

AnimalsB-LymphocytesFemaleHumansMice, Inbred C57BLOvarian NeoplasmsPeritoneal CavityPeritoneumB-Lymphocyte SubsetsMice

Keywords

BiologyOvarian cancerMarginal zonePeritoneal cavityImmunologyCancer researchContext (archaeology)B cellCancerGeneticsAntibodyB1 cellsMarginal Zone B cellsTumor microenvironment

Sustainable Development Goals

SDG 0: Good health and well-being